Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Desk lamp that boosts mood and fights drowsiness tested in new study

NCT ID NCT05619133

Symptom relief Sponsor: Seaborough Life Science B.V. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a desk lamp that gives off near-infrared light can help people who feel sleepy or down during the day. Eighty healthy adults aged 25 to 65 used the lamp at their desk for two weeks. Researchers checked changes in mood, drowsiness, sleep quality, and blood markers to see if the light made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
near-infrared light from a modified desk lamp
What this could lead to
If it works, this could offer a simple, non-drug way to boost energy and mood using light at your desk.
What could go wrong
This is a small, early study with only 80 people. The effects may be small or not last, and the lamp setup might not be practical for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2023

Finished

Apr 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Healthy, no chronic disease * Age between 25 - 65 years. * Suffer from daytime sleepiness/drowsiness and or a mild mood disturbance (ESS \>5 or BDI equal to or higher than 13 but lower than 20, PSQI \> 5) * Participants will have to have a desk type of work and/or have 3 hours per day between 9:30 am and 12:30 at their office/home in which they could sit in front of the lamp. Exclusion Criteria: Depressive mood (BDI -II \> 20) * Pregnancy * Menopause symptoms * Drug use during the last three months known to interfere with sleep, alertness, the biological clock and/or light sensitivity (i.e. regular usage of sleep medication or stimulating substances) * Use of immune suppressants. High levels of caffeine intake during a day (5 or more cups, according to https://www.voedingscentrum.nl/encyclopedie/cafeine.aspx#blok7, there are no negative effects expected from 4 caffeine products in normal adults) * High alcohol intake (more than 4 for men and more than 3 for women, drinks per day) for more than 5 days in the past month, including binge drinking and heavy drinking according to https://www.niaaa.nih.gov/publications/brochures-and- fact-sheets/alcohol-facts-and-statistics. * Participant is not able to refrain from using recreational drugs during the 4 weeks of the study. * Shift work schedule in the 3 months prior to participation and/or planned during the 2 weeks of the study * Environmental factors in everyday life that may disturb sleep and cannot be prohibited (e.g. young children, noisy environment) * Travel over 2 or more time zones in the month prior to participation * Travel to sunny holiday locations/wintersports 1 month before participation * Personal plans that prevent them for using the intervention during 2 consecutive weeks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Circadian rhythm disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronobiology Disorders circadian rhythm sleep disorder Sleep Deprivation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Circadian rhythm disorders Sleep deprivation

Contacts and locations

Locations

  • Chrono@Work

    Groningen, 9743 AD, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.